MigVax Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Crowdfunding
- Latest Deal Amount
-
$290K
- Investors
-
3
MigVax General Information
Description
Developer of vaccines intended to treat diseases including coronavirus and bird flu disease. The company's vaccines incorporates a chimeric protein to stimulate mucosal, systemic, and cell-mediated immune responses, delivered via a freeze-dried tablet that dissolves on the tongue without water, stable at room temperature for two months, and does not require healthcare professionals for administration, enabling medical practitioners to effectively tackle various diseases.
Contact Information
Website
www.migvax.comCorporate Office
- Tarshish Street
- Qiryat Shmona
- Hazafon 11016
- Israel
Corporate Office
- Tarshish Street
- Qiryat Shmona
- Hazafon 11016
- Israel
MigVax Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Equity Crowdfunding | 08-Nov-2022 | $290K | Completed | Generating Revenue | ||
| 2. Grant | 04-Nov-2021 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 08-May-2020 | $12M | $12M | Completed | Generating Revenue |
MigVax Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred A |
MigVax Comparisons
Industry
Financing
Details
MigVax Competitors (41)
One of MigVax’s 41 competitors is AnTolRx, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
| Voyager Therapeutics | Formerly VC-backed | Lexington, MA | ||||
| Baliopharm | Venture Capital-Backed | Basel, Switzerland | ||||
| Gylden Pharma | Venture Capital-Backed | Abingdon, United Kingdom | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA |
MigVax Patents
MigVax Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4297777-A1 | Oral compositions and use of same in vaccination | Inactive | 25-Feb-2021 | ||
| EP-4297777-A4 | Oral compositions and use of same in vaccination | Inactive | 25-Feb-2021 | ||
| US-20240197864-A1 | Oral compositions and use of same in vaccination | Pending | 25-Feb-2021 | ||
| WO-2022180635-A1 | Oral compositions and use of same in vaccination | Inactive | 25-Feb-2021 | A61K9/0053 |
MigVax Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Coalition for Epidemic Preparedness Innovations | Impact Investing | |||
| Happiness Capital | Corporate Venture Capital | Minority | ||
| OurCrowd | Venture Capital | Minority |
MigVax FAQs
-
When was MigVax founded?
MigVax was founded in 2020.
-
Where is MigVax headquartered?
MigVax is headquartered in Hazafon, Israel.
-
What industry is MigVax in?
MigVax’s primary industry is Drug Discovery.
-
Is MigVax a private or public company?
MigVax is a Private company.
-
What is MigVax’s current revenue?
The current revenue for MigVax is .
-
How much funding has MigVax raised over time?
MigVax has raised $12.3M.
-
Who are MigVax’s investors?
Coalition for Epidemic Preparedness Innovations, Happiness Capital, and OurCrowd have invested in MigVax.
-
Who are MigVax’s competitors?
AnTolRx, Voyager Therapeutics, Baliopharm, Gylden Pharma, and Inovio Pharmaceuticals are some of the 41 competitors of MigVax.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process